These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3361655)
21. Effects of drinking water quality on urinary parameters in men with and without urinary tract stones. Mirzazadeh M; Nouran MG; Richards KA; Zare M Urology; 2012 Mar; 79(3):501-7. PubMed ID: 22173182 [TBL] [Abstract][Full Text] [Related]
22. High fluid intake or pharmacological therapy in recurrent stone former patients? Aroldi A; Graziani G; Passerini P; Castelnovo C; Mandressi A; Trinchieri A; Colussi G; Ponticelli C Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():743-6. PubMed ID: 3991571 [TBL] [Abstract][Full Text] [Related]
23. Changes in urine volume accomplished by physicians treating nephrolithiasis. Parks JH; Goldfischer ER; Coe FL J Urol; 2003 Mar; 169(3):863-6. PubMed ID: 12576800 [TBL] [Abstract][Full Text] [Related]
24. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kumar V; Peña de la Vega L; Farell G; Lieske JC Kidney Int; 2005 Oct; 68(4):1784-92. PubMed ID: 16164655 [TBL] [Abstract][Full Text] [Related]
27. Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. I: Effect of casting solvent on hydration properties. Azoury R; Elkayam R; Friedman M J Pharm Sci; 1988 May; 77(5):425-7. PubMed ID: 3411466 [TBL] [Abstract][Full Text] [Related]
28. [Is it necessary to systematically reduce dietary calcium intake in lithiasic patients?]. Fuss M; Van Geel J; Pepersack T; Bergmann P; Van de Walle JC; Simon J Acta Urol Belg; 1988; 56(4):511-5. PubMed ID: 3207083 [No Abstract] [Full Text] [Related]
29. A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. Morse RM; Resnick MI J Urol; 1988 Apr; 139(4):869-73. PubMed ID: 3352063 [TBL] [Abstract][Full Text] [Related]
30. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers. Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942 [TBL] [Abstract][Full Text] [Related]
31. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507 [TBL] [Abstract][Full Text] [Related]
32. Effect of ascorbic acid consumption on urinary stone risk factors. Traxer O; Huet B; Poindexter J; Pak CY; Pearle MS J Urol; 2003 Aug; 170(2 Pt 1):397-401. PubMed ID: 12853784 [TBL] [Abstract][Full Text] [Related]
33. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278 [TBL] [Abstract][Full Text] [Related]
34. The most important metabolic risk factors in recurrent urinary stone formers. Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S Urol J; 2011; 8(2):99-106. PubMed ID: 21656467 [TBL] [Abstract][Full Text] [Related]